202 related articles for article (PubMed ID: 33541399)
21. PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis.
Augello C; Gianelli U; Falcone R; Tabano S; Savi F; Bonaparte E; Ciboddo M; Paganini L; Parafioriti A; Ricca D; Lonati S; Cattaneo D; Fracchiolla NS; Iurlo A; Cortelezzi A; Bosari S; Miozzo M; Sirchia SM
Leuk Res; 2015 Feb; 39(2):236-41. PubMed ID: 25498506
[TBL] [Abstract][Full Text] [Related]
22. Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis.
Guglielmelli P; Pacilli A; Rotunno G; Rumi E; Rosti V; Delaini F; Maffioli M; Fanelli T; Pancrazzi A; Pietra D; Salmoiraghi S; Mannarelli C; Franci A; Paoli C; Rambaldi A; Passamonti F; Barosi G; Barbui T; Cazzola M; Vannucchi AM;
Blood; 2017 Jun; 129(24):3227-3236. PubMed ID: 28351937
[TBL] [Abstract][Full Text] [Related]
23. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2013 Feb; 88(2):141-50. PubMed ID: 23349007
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations.
Nielsen HM; Andersen CL; Westman M; Kristensen LS; Asmar F; Kruse TA; Thomassen M; Larsen TS; Skov V; Hansen LL; Bjerrum OW; Hasselbalch HC; Punj V; Grønbæk K
Sci Rep; 2017 Jul; 7(1):6774. PubMed ID: 28754985
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation profiling: comparison of genome-wide sequencing methods and the Infinium Human Methylation 450 Bead Chip.
Walker DL; Bhagwate AV; Baheti S; Smalley RL; Hilker CA; Sun Z; Cunningham JM
Epigenomics; 2015; 7(8):1287-302. PubMed ID: 26192535
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.
Iurlo A; Palandri F; Maria Elli E; Cattaneo D; Bucelli C; Sciumè M; Vincelli D; Brioschi F; Auteri G; Croci GA; Guerneri S; Isimbaldi G; Sabattini E; Cortinovis I; Bossi A; Rosti V; Martino B; Baldini L; Gianelli U
Hematol Oncol; 2021 Feb; 39(1):123-128. PubMed ID: 32979286
[TBL] [Abstract][Full Text] [Related]
27. High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis.
Hasselbalch HC; Skov V; Larsen TS; Thomassen M; Riley CH; Jensen MK; Bjerrum OW; Kruse TA
Leuk Res; 2011 Oct; 35(10):1330-4. PubMed ID: 21470677
[TBL] [Abstract][Full Text] [Related]
28. Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and
Martínez-Calle N; Pascual M; Ordoñez R; Enériz ESJ; Kulis M; Miranda E; Guruceaga E; Segura V; Larráyoz MJ; Bellosillo B; Calasanz MJ; Besses C; Rifón J; Martín-Subero JI; Agirre X; Prosper F
Haematologica; 2019 Aug; 104(8):1572-1579. PubMed ID: 30655376
[TBL] [Abstract][Full Text] [Related]
29. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
[TBL] [Abstract][Full Text] [Related]
30. A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis.
Carobbio A; Guglielmelli P; Rumi E; Cavalloni C; De Stefano V; Betti S; Rambaldi A; Finazzi MC; Thiele J; Vannucchi AM; Tefferi A; Barbui T
Blood Cancer J; 2020 Oct; 10(10):100. PubMed ID: 33056979
[TBL] [Abstract][Full Text] [Related]
31. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
Barbui T; Thiele J; Passamonti F; Rumi E; Boveri E; Ruggeri M; Rodeghiero F; d'Amore ES; Randi ML; Bertozzi I; Marino F; Vannucchi AM; Antonioli E; Carrai V; Gisslinger H; Buxhofer-Ausch V; Müllauer L; Carobbio A; Gianatti A; Gangat N; Hanson CA; Tefferi A
J Clin Oncol; 2011 Aug; 29(23):3179-84. PubMed ID: 21747083
[TBL] [Abstract][Full Text] [Related]
32. Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.
Muth M; Engelhardt BM; Kröger N; Hussein K; Schlué J; Büsche G; Kreipe HH; Bock O
Ann Hematol; 2011 Jan; 90(1):33-40. PubMed ID: 20625903
[TBL] [Abstract][Full Text] [Related]
33. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
34. The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation.
Li K; Qin L; Jiang S; Li A; Zhang C; Liu G; Sun J; Sun H; Zhao Y; Li N; Zhang Y
Clin Epigenetics; 2020 Jun; 12(1):81. PubMed ID: 32513305
[TBL] [Abstract][Full Text] [Related]
35. Genome wide DNA methylation profiling identifies specific epigenetic features in high-risk cutaneous squamous cell carcinoma.
Hervás-Marín D; Higgins F; Sanmartín O; López-Guerrero JA; Bañó MC; Igual JC; Quilis I; Sandoval J
PLoS One; 2019; 14(12):e0223341. PubMed ID: 31860637
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
38. Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2016 Dec; 91(12):1262-1271. PubMed ID: 27870387
[TBL] [Abstract][Full Text] [Related]
39. CD18 promoter methylation is associated with a higher risk of thrombotic complications in primary myelofibrosis.
Augello C; Cattaneo D; Bucelli C; Terrasi A; Fermo E; Martinelli I; Iurlo A; Gianelli U
Ann Hematol; 2016 Dec; 95(12):1965-1969. PubMed ID: 27595148
[TBL] [Abstract][Full Text] [Related]
40. Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study.
Al-Ghamdi YA; Lake J; Bagg A; Thakral B; Wang SA; Bueso-Ramos C; Masarova L; Verstovsek S; Rogers HJ; Hsi ED; Gralewski JH; Chabot-Richards D; George TI; Rets A; Hasserjian RP; Weinberg OK; Parilla M; Arber DA; Padilla O; Orazi A; Tam W
Mod Pathol; 2023 Mar; 36(3):100016. PubMed ID: 36788093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
